Neurotensin (8-13) is an active fragment of Neurotensin,. Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density.
CAT No: R1550
CAS No:60482-95-3
Synonyms/Alias:Neurotensin(8-13);60482-95-3;neurotensin (8-13);L-Arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine;CHEMBL415788;(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid;Neurotensin (8-13) H-Arg-Arg-Pro-Tyr-Ile-Leu-OH;NT(8-13);Neurotensin (8-13) acetate salt;neurotensin-(8-13);GTPL7363;HY-P0251;BDBM50048908;AKOS037649204;BS-17187;DA-76141;FN108541;D80643;H-Arg-Arg-Pro-Tyr-Ile-Leu-OH; H-RRPYIL-OH;L-Leucine,L-arginyl-L-arginyl-L-prolyl-L-tyrosyl-L-isoleucyl-;
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More